German Health Minister Horst Seehofer has agreed to change a controversial feature of the third draft health service reform legislation, permitting health funds to increase their premiums without a corresponding rise in patient contributions to the cost of their drugs, medicines and treatment.
Meantime, Rudolf Dressler, chairman of the Social Democratic Party's parliamentary committee, says the third-phase reform will lead to a "drastic rise in costs." He says the current health fund deficit will have topped 14 billion Deutschemarks ($9.37 billion) by the end of 1996, making "massive increases in premiums" unavoidable for most funds in 1997.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze